Diffuse large B cell lymphoma classification: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 5: Line 5:
==Overview==
==Overview==
Diffuse large B cell lymphoma may be classified into  variants, subgroups, subtypes, and entities based on the World Health Organization Classification (WHO).  
Diffuse large B cell lymphoma may be classified into  variants, subgroups, subtypes, and entities based on the World Health Organization Classification (WHO).  
==Overview==
Diffuse large B cell lymphoma may be classified based on location into nodal and extranodal disease and based on molecular, genetic, and immunohistochemical features into more than 20 subgroups.


==Classification==
==Classification==
Diffuse large B-cell lymphoma encompasses a biologically and clinically diverse set of diseases,<ref name="Alizadeh2000">{{cite journal |doi=10.1038/35000501 |pmid=10676951 |title=Distinct types of diffuse large B-cell lymphoma identified by gene expression
Diffuse large B cell lymphoma may be classified based on location:
profiling |journal=Nature |volume=403 |issue=6769 |pages=503–11 |year=2000 |last1=Alizadeh |first1=Ash A. |last2=Eisen |first2=Michael B. |last3=Davis |first3=R. Eric |last4=Ma |first4=Chi |last5=Lossos |first5=Izidore S. |last6=Rosenwald |first6=Andreas |last7=Boldrick |first7=Jennifer C. |last8=Sabet |first8=Hajeer |last9=Tran |first9=Truc |last10=Yu |first10=Xin |last11=Powell |first11=John I. |last12=Yang |first12=Liming |last13=Marti |first13=Gerald E. |last14=Moore |first14=Troy |last15=Hudson |first15=James |last16=Lu |first16=Lisheng |last17=Lewis |first17=David B. |last18=Tibshirani |first18=Robert |last19=Sherlock |first19=Gavin |last20=Chan |first20=Wing C. |last21=Greiner |first21=Timothy C. |last22=Weisenburger |first22=Dennis D. |last23=Armitage |first23=James O. |last24=Warnke |first24=Roger |last25=Levy |first25=Ronald |last26=Wilson |first26=Wyndham |last27=Grever |first27=Michael R. |last28=Byrd |first28=John C. |last29=Botstein |first29=David |last30=Brown |first30=Patrick O. |display-authors=29 |bibcode=2000Natur.403..503A }}</ref> many of which cannot be separated from one another by well-defined and widely accepted criteria.
*Nodal disease
*Extranodal disease


The [[World Health Organization]] (WHO) classification system defines more than a dozen subtypes, each of which can be differentiated based on the
According to the WHO 2008 classification, diffuse large B cell lymphoma may be classified based on molecular, genetic, and immunohistochemical features into the following:<ref name=WHO>{{cite book |last=Stein H, Chan JKC, Warnke RA |date=2008 |title=Diffuse large B-cell lymphoma not otherwise specified. In:Swerdlow SH, Campo E, Harris NL, et al. editors. WHO classification of tumours of haematopoietic and lymphoid tissues |location=Lyon |publisher=IARC |page=233-7 |isbn=}}</ref>
*Location of the tumor
===Diffuse large B cell lymphoma, not otherwise specified===
*Presence of other cells within the tumor (such as [[T cell]]s)
====Morphologic subgroups====
*Other illnesses related to diffuse large B-cell lymphoma.
* Centroblastic
:*One of these well-defined groupings of particular note is Primary mediastinal B-cell lymphoma, which arises within the [[thymus]] or mediastinal lymph nodes.
* Immunoblastic
* Anaplastic
*Other
====Immunophenotypic subgroups====
* Germinal center-derived B-cell (GCB)
* Activated B-cell-like (ABC)  
====Genetic subgroups====
*''BCL6''
*''BCL2''
*''C-MYC''
*Other
====Immunohistochemical subgroups====
* CD5-positive de-novo diffuse large B cell lymphoma
* Germinal center B-cell like (GCB)
*Non-germinal center B-cell-like (non-GCB)


Diffuse large B-cell lymphoma, not otherwise specified
===Diffuse Large B Cell Lymphoma subtypes===
*When a case of Diffuse large B-cell lymphoma does not conform to any of the well-defined subtypes, and is also not considered unclassifiable.
*T-cell/histiocyte-rich large B cell lymphoma
*The majority of Diffuse large B-cell lymphoma cases fall into this category.
*Primary diffuse large B cell lymphoma of the central nervous system (CNS)
*Much research has been devoted to separating this still-heterogeneous group; such distinctions are usually made along lines of
*Epstein-Barr virus positive diffuse large B cell lymphoma of the elderly
:*[[Morphology (biology)|cellular morphology]]
:*[[gene expression]]
:*[[Immunohistochemistry|immunohistochemical]] properties.


===Diffuse large B-cell lymphoma (DLBCL): variants, subgroups, subtypes, and entities based on the World Health Organization Classification (WHO)===
===Other lymphomas of large B cells===
===DLBCL, not otherwise specified (DLBCL, NOS)===
* Common morphological variants
:* Centroblastic
:* Immunoblastic
:* Anaplastic
* Rare morphological variants
* Molecular subgroups
:* Germinal center B-cell-like (GCB)
:* Activated B-cell-like (ABC)
* Immunohistochemical subgroups
:* CD5-positive DLBCL
:* Germinal center B-cell-like (GCB)
:* Non-germinal center B-cell-like (non-GCB)
===DLBCL subtypes===
* T-cell-/histiocyte-rich large B-cell lymphoma
* Primary DLBCL of the central nervous system
* Primary cutaneous DLBCL
* Leg type EBV-positive DLBCL of the elderly
===Other lymphomas of large B-cells===
* Primary mediastinal (thymic) large B-cell lymphoma
* Primary mediastinal (thymic) large B-cell lymphoma
* Intravascular large B-cell lymphoma
* Intravascular large B-cell lymphoma
Line 52: Line 48:
* Large B-cell lymphoma arising in HHV8-associated multicentric Castleman disease
* Large B-cell lymphoma arising in HHV8-associated multicentric Castleman disease
* Primary effusion lymphoma
* Primary effusion lymphoma
===Borderline cases B-cell lymphoma===  
===Borderline cases B-cell lymphoma===  
*Unclassifiable, with features intermediate between DLBCL and Burkitt lymphoma B-cell lymphoma,  
*Unclassifiable, with features intermediate between DLBCL and Burkitt lymphoma B-cell lymphoma,  

Revision as of 01:16, 25 August 2015

Diffuse large B cell lymphoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Diagnosis

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Biopsy

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Diffuse large B cell lymphoma classification On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Diffuse large B cell lymphoma classification

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Diffuse large B cell lymphoma classification

CDC on Diffuse large B cell lymphoma classification

Diffuse large B cell lymphoma classification in the news

Blogs on Diffuse large B cell lymphoma classification

Directions to Hospitals Treating Diffuse large B cell lymphoma

Risk calculators and risk factors for Diffuse large B cell lymphoma classification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Diffuse large B cell lymphoma may be classified into variants, subgroups, subtypes, and entities based on the World Health Organization Classification (WHO).

Overview

Diffuse large B cell lymphoma may be classified based on location into nodal and extranodal disease and based on molecular, genetic, and immunohistochemical features into more than 20 subgroups.

Classification

Diffuse large B cell lymphoma may be classified based on location:

  • Nodal disease
  • Extranodal disease

According to the WHO 2008 classification, diffuse large B cell lymphoma may be classified based on molecular, genetic, and immunohistochemical features into the following:[1]

Diffuse large B cell lymphoma, not otherwise specified

Morphologic subgroups

  • Centroblastic
  • Immunoblastic
  • Anaplastic
  • Other

Immunophenotypic subgroups

  • Germinal center-derived B-cell (GCB)
  • Activated B-cell-like (ABC)

Genetic subgroups

  • BCL6
  • BCL2
  • C-MYC
  • Other

Immunohistochemical subgroups

  • CD5-positive de-novo diffuse large B cell lymphoma
  • Germinal center B-cell like (GCB)
  • Non-germinal center B-cell-like (non-GCB)

Diffuse Large B Cell Lymphoma subtypes

  • T-cell/histiocyte-rich large B cell lymphoma
  • Primary diffuse large B cell lymphoma of the central nervous system (CNS)
  • Epstein-Barr virus positive diffuse large B cell lymphoma of the elderly

Other lymphomas of large B cells

  • Primary mediastinal (thymic) large B-cell lymphoma
  • Intravascular large B-cell lymphoma
  • DLBCL associated with chronic inflammation
  • Lymphomatoid granulomatosis
  • ALK-positive LBCL
  • Plasmablastic lymphoma
  • Large B-cell lymphoma arising in HHV8-associated multicentric Castleman disease
  • Primary effusion lymphoma

Borderline cases B-cell lymphoma

  • Unclassifiable, with features intermediate between DLBCL and Burkitt lymphoma B-cell lymphoma,
  • Unclassifiable, with features intermediate between DLBCL and classical Hodgkin lymphoma

Baed on Microscopic pathology

File:215px-diffuse large B cell lymphoma - cytology low mag.jpg
Micrograph of a diffuse large B cell lymphoma


  • Three variants are most commonly seen: centroblastic, immunoblastic, and anaplastic.

Centroblastic

  • Most cases of are diffuse large B cell lymphoma centroblastic, having the appearance of medium-to-large-sized lymphocytes with scanty cytoplasm.
  • Oval or round nuclei containing fine chromatin are prominently visible, having two to four nucleoli within each nucleus.
  • Sometimes the tumour may be monomorphic, composed almost entirely of centroblasts.
  • However, most cases are polymorphic, with a mixture of centroblastic and immunoblastic cells.

Immunoblastic

  • Immunoblasts have significant basophilic cytoplasm and a central nucleolus.
  • A tumour can be classified as immunoblastic if greater than 90% of its cells are immunoblasts. This distinction can be problematic, however, because hematopathologists reviewing the microscope slides may often disagree on whether a collection of cells is best characterized as centroblasts or immunoblasts.[2] Such disagreement indicates poor inter-rater reliability.

Anaplastic

  • The third morphologic variant, anaplastic, consists of tumour cells which appear very differently from their normal B cell counterparts.
  • The cells are generally very large with a round, oval, or polygonal shape and pleomorphic nuclei, and may resemble Hodgkin cells or Reed-Sternberg cells.

References

  1. Stein H, Chan JKC, Warnke RA (2008). Diffuse large B-cell lymphoma not otherwise specified. In:Swerdlow SH, Campo E, Harris NL, et al. editors. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC. p. 233-7.
  2. Harris, N. L.; Jaffe, E. S.; Stein, H; Banks, P. M.; Chan, J. K.; Cleary, M. L.; Delsol, G; De Wolf-Peeters, C; Falini, B; Gatter, K. C. (1994). "A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group". Blood. 84 (5): 1361–92. PMID 8068936.


Template:WikiDoc Sources